Shares of Dexcom fell 9% in extended trading on Thursday after the company released third-quarter results that beat analysts' expectations but showed a decline in U.S. revenue year over year. Here's how the company did:Earnings per share: 45 cents adjusted vs. 43 cents expected by LSEG45 cents adjusted vs. 43 cents expected by LSEG Revenue: $994 million vs. $990 million expected by LSEGThe company's revenue increased 2% to $994.2 million from $975 million a year earlier. The company maintained its full fiscal year guidance and expects revenue of $4 billion to $4.05 billion. Last quarter, Dexcom lowered its guidance from the $4.20 billion to $4.35 billion it forecast in the first quarter. This lowered guidance and a revenue miss caused Dexcom shares to tumble more than 40% following the release of its second-quarter results in July.

---

Persons: Dexcom, Kevin Sayer, Sayer, Teri Lawver, Lawver Organizations: LSEG Revenue, Dexcom